S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
66,000% upside on tiny biotech? (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
66,000% upside on tiny biotech? (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
66,000% upside on tiny biotech? (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
66,000% upside on tiny biotech? (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian stocks follow Wall St up after strong US jobs report
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
OTCMKTS:MRMD

MariMed (MRMD) Stock Forecast, Price & News

$0.41
0.00 (0.00%)
(As of 06/2/2023 08:49 PM ET)
Compare
Today's Range
$0.40
$0.44
50-Day Range
$0.37
$0.52
52-Week Range
$0.28
$0.77
Volume
157,000 shs
Average Volume
254,175 shs
Market Capitalization
$142.73 million
P/E Ratio
20.51
Dividend Yield
N/A
Price Target
$0.85

MariMed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
107.3% Upside
$0.85 Price Target
Short Interest
Healthy
0.01% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.02 out of 5 stars


MRMD stock logo

About MariMed (OTCMKTS:MRMD) Stock

MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. It focuses on the development, operation, management, and optimization of facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis and cannabis-infused products. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.

Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

MRMD Stock News Headlines

MariMed (OTC: MRMD)
“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
MariMed Reports First Quarter 2023 Earnings
Contrasting MariMed (OTCMKTS:MRMD) and Mannatech (NASDAQ:MTEX)
Pentagon Consultant—Here's how Biden Wins Landslide Re-election
—but also hand Joe Biden a landslide re-election win. What would America look like if we slide further towards Socialism? Full story and 4 steps you can take,
MariMed Inc. (OTCMKTS:MRMD) Short Interest Update
MariMed Announces First Quarter 2023 Earnings Date
MariMed Stock (OTC:MRMD), Dividends
MariMed Announces Fourth Quarter 2022 Earnings Date
MariMed Inc. (OTC:MRMD) Q3 2022 Earnings Call Transcript
See More Headlines

MRMD Price History

MRMD Company Calendar

Last Earnings
11/15/2021
Today
6/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:MRMD
Fax
N/A
Employees
260
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$0.85
High Stock Price Forecast
$0.85
Low Stock Price Forecast
$0.85
Forecasted Upside/Downside
+107.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$13.47 million
Pretax Margin
9.80%

Debt

Sales & Book Value

Annual Sales
$134.01 million
Cash Flow
$0.06 per share
Book Value
$0.19 per share

Miscellaneous

Free Float
266,874,000
Market Cap
$142.73 million
Optionable
Not Optionable
Beta
2.99

Key Executives

  • Jon R. Levine
    President, CEO, Secretary, Treasurer & Director
  • Timothy Shaw
    Chief Operating Officer
  • Susan M. Villare
    Chief Financial Officer
  • Jay O’Malley
    Vice President-Marketing & Research & Development
  • Ryan Crandall
    Chief Revenue Officer













MRMD Stock - Frequently Asked Questions

Should I buy or sell MariMed stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MariMed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MRMD shares.
View MRMD analyst ratings
or view top-rated stocks.

What is MariMed's stock price forecast for 2023?

1 analysts have issued 12 month target prices for MariMed's stock. Their MRMD share price forecasts range from $0.85 to $0.85. On average, they anticipate the company's stock price to reach $0.85 in the next twelve months. This suggests a possible upside of 107.3% from the stock's current price.
View analysts price targets for MRMD
or view top-rated stocks among Wall Street analysts.

How have MRMD shares performed in 2023?

MariMed's stock was trading at $0.3562 at the beginning of the year. Since then, MRMD shares have increased by 15.1% and is now trading at $0.41.
View the best growth stocks for 2023 here
.

Are investors shorting MariMed?

MariMed saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 16,000 shares, an increase of 100.0% from the April 15th total of 8,000 shares. Based on an average trading volume of 512,100 shares, the short-interest ratio is presently 0.0 days.
View MariMed's Short Interest
.

How were MariMed's earnings last quarter?

MariMed Inc. (OTCMKTS:MRMD) announced its earnings results on Monday, November, 15th. The company reported $0.01 earnings per share for the quarter. The business earned $33.21 million during the quarter. MariMed had a trailing twelve-month return on equity of 17.80% and a net margin of 6.30%.

What guidance has MariMed issued on next quarter's earnings?

MariMed updated its FY 2023 earnings guidance on Monday, May, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $150.00M-, compared to the consensus revenue estimate of $149.65 million.

What other stocks do shareholders of MariMed own?
What is MariMed's stock symbol?

MariMed trades on the OTCMKTS under the ticker symbol "MRMD."

How do I buy shares of MariMed?

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MariMed's stock price today?

One share of MRMD stock can currently be purchased for approximately $0.41.

How much money does MariMed make?

MariMed (OTCMKTS:MRMD) has a market capitalization of $142.73 million and generates $134.01 million in revenue each year. The company earns $13.47 million in net income (profit) each year or $0.02 on an earnings per share basis.

How many employees does MariMed have?

The company employs 260 workers across the globe.

How can I contact MariMed?

MariMed's mailing address is 11 ROYAL ROAD, BROOKLINE MA, 02445. The official website for the company is marimedadvisors.com. The company can be reached via phone at (617) 795-5140 or via email at ir@mattio.com.

This page (OTCMKTS:MRMD) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -